Education and Training:
Pharm.D. degree from the University of Illinois-Chicago in 1998.

Psychiatric Pharmacy Residency at The University of Texas at Austin and Austin State Hospital, 1998-1999.

Clinical Sciences Fellowship in Psychiatric Pharmacy at The University of Texas at Austin and Texas Department of Mental Health and Mental Retardation, 1999-2001

Board Certifications:
Psychiatric Pharmacy Practice, Board of Pharmaceutical Specialties

Licensed to practice pharmacy in Texas

Research and Professional Interests:
During her fellowship, Dr. Bettinger evaluated physician adherence to the TMAP depression algorithm in the "real world" setting. Dr. Bettinger has assisted in training clinicians and staff throughout Texas and several other states on the use of the TMAP algorithms. She also assisted in the development and initial pilot studies involving the computerized version of TMAP, CompTMAP.

Currently, Dr. Bettinger's research interests involve the detection and treatment of mental illnesses in the primary care setting, patient adherence, and the use of treatment algorithms in mental health. Dr. Bettinger is involved in several ongoing projects in the area of mental health outcomes including: evaluation of a psychiatric pharmacy consult service; utilization, predictors and effectiveness of antipsychotic polypharmacy; symptom profiles of children and adolescents with ADHD, bipolar disorder or depression; and improving patient outcomes in primary care in patients with depression and diabetes.

Dr. Bettinger received the National Institute of Mental Health's New Clinical Drug Evaluation Unit New Investigator's Award in 2002 and the United States Pharmacopeia Fellowship Award in 2000. She is also a recipient of the NARSAD Young Investigator award (2003-2005).

In collaboration with other faculty in the Divisions of Pharmacy Practice and Pharmacy Administration, Dr. Bettinger is involved in clinical training program in psychiatric pharmacotherapy and mental health outcomes. This program offers a M.S. or Ph.D. degree combined with a residency in psychiatric pharmacotherapy.

Information regarding application for graduate school at The University of Texas College of Pharmacy can be obtained at: http://www.utexas.edu/pharmacy/admissions/graduate

Additional information about the residency in psychiatric pharmacy practice can be obtained at: http://www.utexas.edu/pharmacy/divisions/pharmaco/postdoc/psych_aus.html

Selected Publications:
Bettinger TL, Crismon ML. Lithium. Burton M, Evans W, Schentag J, Shaw L, (eds). Applied pharmacokinetics: principles of therapeutic drug monitoring, 4th ed. Baltimore: Lippincott Williams & Wilkins. (in press)

Trivedi MH, Bettinger TL, Kleiber B. Treatment Resistant Depression. In: Preskorn S, ed. Handbook of Experimental Pharmacology on Antidepressants. New York: Springer-Verlag. (in press)

Winans EA, Bettinger TL. Mood Disorders: Bipolar and Major Depressive Disorders. In: Schumock GT, Brundage DM, Chessman KH, et al, eds. Pharmacotherapy Self-Assessment Program, 5th ed. Psychiatry I module. Kansas City, Missouri: American College of Clinical Pharmacy. (in press)

Bettinger TL, Crismon ML, Trivedi MH, Grannemann B, Shon S. Clinician adherence to a major depressive disorder algorithm in the public mental health sector. Psychiatric Services 2004;55:703-705.

Trivedi MH, Kern JK, Marcee AK, Kleiber B, Grannemann B, Bettinger T, Altshuler KZ, McClelland A. Development and implementation of computerized clinical guidelines: barriers and solutions. Methods Inf Med. 2002;41(5):435-42.

Patel N, Dorson PG, Bettinger TL. Sudden late onset of clozapine induced agranulocytosis: implications for hematologic monitoring. Ann Pharmacother 2002;36:1012-5.

Bettinger T, Trivedi MH. Newer antidepressant medications. DMJ 2001;87:522-526.

Bettinger TL, Mendelson SC, Dorson PG, Crismon ML. Olanzapine-induced glucose dysregulation. Ann Pharmacother 2000;34:865-7.